Skip to content

Clinical trials

Hyperkalemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperkalemia Clear all

131 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20051
20082
20093
20102
20112
20121
20132
20147
20153
20164
201713
20184
20199
20208
202119
202214
20234
202410
202512
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed79
Terminated14
Recruiting12
Unknown status11
Not yet recruiting6
Active, not recruiting5
Enrolling by invitation3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca29
ZS Pharma, Inc.8
Relypsa, Inc.7
Vifor Pharma, Inc.3
Waterstone Pharmaceutical (Wuhan) Co., LTD.3
Ardelyx2
Karolinska Institutet2
Mario Negri Institute for Pharmacological Research2
National Defense Medical Center, Taiwan2
Peking University First Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperkalemia131
Renal Insufficiency, Chronic40
Heart Failure11
Hypertension7
Hypokalemia6
Kidney Failure, Chronic6
Acute Kidney Injury4
Diabetic Nephropathies4
Acidosis3
Albuminuria3

Trials

Showing 76 to 100 of 131. Each trial links to its page on Pharma Observatory.

31 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.